Status
Conditions
About
This project aims to fill this essential knowledge gap by assessing the impact of oral cholera vaccine mass campaigns in 2 sites (urban and rural) in DRC, described in this protocol. The evidence generated from this project will be key to develop future strategies regarding cholera vaccine use in endemic settings, including places with higher burden in terms of cholera mortality
Full description
The project will comprise three different components:
Clinical cholera surveillance to measure cholera diseases incidence in selected African hotspots targeted by vaccination.
Serial serological surveys to measure the prevalence of recent cholera infection (within the last 12 months).
Identification and follow up of individuals with positive V. cholerae shedding (symptomatic or asymptomatic) among sero-survey participants and among household members of cholera confirmed cases.
The present protocol relates to the setup of seroprevalence surveys and the follow up of individuals with positive V. cholerae shedding identified through seroprevalence surveys, in DRC.
This protocol will allow us to assess if a large vaccination campaign reaching high coverage in cholera hotspot in Africa can allow sustained control of cholera for at least two years, by fulfilling the following specific objectives:
Enrollment
Sex
Volunteers
Inclusion criteria
All persons,
Exclusion criteria
Loading...
Central trial contact
Anais Broban; Emily Briskin
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal